Vusion · EURONEXT:VU
Vusion — H1 2020 Earnings Presentation
12 slides from Vusion's earnings presentation, September 2020
Slide 1: H1 Results Investor Conference Call
H1 RESULTS INVESTOR CONFERENCE CALL PARIS, SEPT 2020 1
Slide 2: 2020 H1 Results
2020 H1 RESULTS H1 sales slightly down at €118m (-2.5% vs. H1 2019) H1 2020 H1 2019 Δ Profitability affected by the impact of 2020/2019 COVID on the geographic mix Reported H1 EUR/USD At 2019 2020 / Reported exchange EUR/USD Reported reported H1 rate rate H1 EBITDA at -€0.2m (€1.9m at constant impac
Slide 3: 12-Month Rolling Sales
12-MONTH ROLLING SALES (€M) HY 12 month rolling 200 300 248 244 228 250 150 200 121 126 118 100 150 100 50 50 0 0 2019-H1 2019-H2 2020-H1 3
Slide 4: H1 Order Entries
H1 Order Entries (€m) HY 12 month rolling 300 379 400 336 350 250 300 H1-2020 200 237 213 166 M€ 250 +34% vs 2019 150 166 200 123 150 100 100 50 50 0 0 2019-H1 2019-H2 2020-H1 4
Slide 5: H1 2020 Group P&L
H1 2020 GROUP P&L H1 2020 H1 2019 Δ 2020/2019 At 2019 EUR/USD Reported H1 2020 / Reported EUR/USD Reported exchange rate reported H1 2019 rate impact Revenues 118.4 0.8 117.6 121.4 -2% Variable Costs Margin 22.6 (1.4) 23.9 25.6 -12% % of revenues 19.1% 20.3% 21.1% -2.0 pt Opex (22.8) (22.8) (22.5) 1
Slide 6: EBITDA impacted by Covid-19
EBITDA impacted by Covid-19 €m In H1 Opex are 0.3M€ higher than in H1 2019 but 1.2M€ lower than in H2 2019 -0.6 -1.0 3.1 -0.3 1.1 -1.4 -0.2 EBITDA H1 2019 Volume effect VCM rate impact Opex EBITDA H1 2020 EUR/USD impact EBITDA H1 2020 at constant reported EUR/USD exchange rate 6
Slide 7: Contingency plan: OPEX under control
Contingency plan: OPEX under control -23% Q3 2019 Q4 2019 Q1 2020 Q2 2020 7
Slide 8: EBIT to EBITDA reconciliation
EBIT to EBITDA reconciliation As of, in €m June 30, 2020 June 30, 2019 Operating Income (EBIT) reported (9.6) (3.9) - GdW amortization (0.5) (0.4) - Equity / debt / M&A related fees (0.3) (0.3) - Others (0.0) (0.1) = Current EBIT (8.8) (3.1) - Fixed & Intangible Asset Depreciation Expense (8.6) (6.2
Slide 9: Cash Flow impacted by Covid
Cash Flow impacted by Covid €m H1 2020 FY 2019 Working Capital impacted by Covid (+€25m) EBITDA before impact of IFRS16 (1.5) 1.7 Increase in inventory Capex (15.5) (36.2) Projects slowed down or postponed Change in Working Capital (25.0) 41.2 Shift to sea transportation Operational Cash-Flow (42.0)
Slide 10: H2 outlook
H2 outlook
Slide 11: H2 outlook
H2 outlook Coronavirus Health prevention measures Mask, social distancing and health & safety rules implemented in all company premises Partial Home office Tight cost control plan to continue in H2 Back to growth in H2 Still some uncertainty about COVID 2nd wave development and possible impact on Q4
Slide 12: Thank you and stay safe!
Thank you and stay safe!